CPS Technologies (CPSH) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
20 Mar, 2026Executive summary
Annual Meeting scheduled for April 30, 2026, with five key proposals for shareholder vote, including director elections, executive compensation, share authorization increase, and auditor ratification.
Shareholders of record as of March 11, 2026, are eligible to vote in person, by proxy card, phone, or online.
Proxy materials, including the annual report and proxy statement, are available online and by request.
Voting matters and shareholder proposals
Proposals include: election of five directors, advisory vote on executive compensation, advisory vote on frequency of say-on-pay, amendment to increase authorized common shares from 20M to 25M, and ratification of PKF O'Connor Davies LLP as auditor.
Board recommends voting for all director nominees, for executive compensation, for annual say-on-pay, for share increase, and for auditor ratification.
Shareholder proposals for the 2027 meeting must be received by November 20, 2026.
Board of directors and corporate governance
Board consists of five independent directors, all meeting Nasdaq independence standards.
Directors and nominees bring diverse experience in management, finance, academia, and industry.
Board held six meetings in 2025; all directors attended at least 75% of meetings.
Two standing committees: Audit Committee and Compensation and Nominating Committee.
Board encourages, but does not require, director attendance at annual meetings.
Latest events from CPS Technologies
- Q2 2026 revenue up to $8.3M, $9.6M raised, and margin recovery amid rising costs.CPSH
Q2 2026 - Q1 2026 revenue and margins declined, but growth and margin recovery are expected ahead.CPSH
Q1 2026 - Annual meeting to vote on directors, executive pay, share increase, and auditor ratification.CPSH
Proxy Filing - Record revenue, margin gains, and facility expansion drive strong growth outlook.CPSH
Q4 2025 - Record revenue, margin gains, and major contracts drive expansion amid ongoing market risks.CPSH
Q3 2025 - Record Q2 2025 revenue, profitability, and strong demand drive a positive outlook.CPSH
Q2 2025 - Q3 revenue fell 32% to $4.2M, but new contracts and capacity boost outlook for 2025.CPSH
Q3 2024 - Revenue and margins fell in Q2, but new contracts and product launches support future growth.CPSH
Q2 2024 - Record Q1 2025 revenue and profitability, with strong growth and improved margins.CPSH
Q1 2025